Title Issue Date
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study de Sanjose, Silvia; Quint, Wim G.V.; Alemany, Laia; Geraets, Daan T.; Klaustermeier, Jo Ellen, et al Issued date: 2010 DOI: 10.1016/S1470-2045(10)70230-8 Source: The Lancet Oncology[ISSN 1470-2045],v. 11, p. 1048-1056 SCIE Artículo
Surgery versus SABR for resectable non-small-cell lung cancer Opitz, Isabelle; Rocco, Gaetano; Brunelli, Alessandro; Varela, Gonzalo; Massard, Gilbert, et al Issued date: 2015 DOI: 10.1016/S1470-2045(15)00123-0 Source: The Lancet Oncology[ISSN 1470-2045],v. 16, p. e372 SJR: 13,825 - Q1 SCIE Comentario
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Garassino, Marina C.; Gadgeel, Shirish; Esteban, Emilio; Felip, Enriqueta; Speranza, Giovanna, et al Issued date: 2020 DOI: 10.1016/S1470-2045(19)30801-0 Source: Lancet Oncology[ISSN 1470-2045],v. 21 (3), p. 387-397, (Marzo 2020) SJR: 13,53 - Q1 JCR: 41,316 - Q1 SCIE Artículo